Ivan Gergel Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ivan Gergel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ivan Gergel. Ivan Gergel is Sr VP - Chief Sci. Officer in Forest Laboratories, LLC ($FRX) and SVP Scientific Affairs in Forest Laboratories, LLC ($FRX) and SVP & Chief Medical Officer in NEKTAR THERAPEUTICS ($NKTR) and Director in Neurotrope, Inc. ($NTRP) and Director in Corium International, Inc. ($CORI).
Latest Insider Trading Transactions of Ivan Gergel
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CORI, FRX, NKTR, NTRP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 03 2020 | NTRP | Neurotrope, Inc. | Gergel Ivan P. | Director | Option Exercise | D | 0.97 | 15,000 | 14,580 | 0 | |
| Dec 03 2020 | NTRP | Neurotrope, Inc. | Gergel Ivan P. | Director | Option Exercise | D | 0.82 | 10,000 | 8,203 | 0 | |
| Dec 03 2020 | NTRP | Neurotrope, Inc. | Gergel Ivan P. | Director | Option Exercise | D | 4.06 | 10,000 | 40,600 | 0 | |
| Dec 03 2020 | NTRP | Neurotrope, Inc. | Gergel Ivan P. | Director | Option Exercise | D | 3.93 | 10,000 | 39,300 | 0 | |
| Dec 03 2020 | NTRP | Neurotrope, Inc. | Gergel Ivan P. | Director | Option Exercise | D | 4.44 | 7,813 | 34,690 | 0 | |
| Nov 27 2020 | NTRP | Neurotrope, Inc. | Gergel Ivan P. | Director | Option Exercise | A | 0.97 | 15,000 | 14,580 | 15,000 | |
| Mar 24 2020 | NTRP | Neurotrope, Inc. | Gergel Ivan P. | Director | Option Exercise | A | 0.82 | 10,000 | 8,203 | 10,000 | |
| Apr 15 2019 | NTRP | Neurotrope, Inc. | Gergel Ivan P. | Director | Option Exercise | A | 4.06 | 10,000 | 40,600 | 10,000 | |
| Jan 24 2019 | NTRP | Neurotrope, Inc. | Gergel Ivan P. | Director | Option Exercise | A | 3.93 | 10,000 | 39,300 | 10,000 | |
| Dec 17 2018 | NTRP | Neurotrope, Inc. | Gergel Ivan P. | Director | Option Exercise | A | 4.44 | 7,813 | 34,690 | 7,813 | |
| Nov 28 2018 | CORI | Corium Internation ... | Gergel Ivan P. | Director | Option Exercise | D | 11.59 | 15,000 | 173,850 | 0 | |
| Nov 28 2018 | CORI | Corium Internation ... | Gergel Ivan P. | Director | Option Exercise | D | 4.59 | 15,000 | 68,850 | 0 | |
| Nov 28 2018 | CORI | Corium Internation ... | Gergel Ivan P. | Director | Option Exercise | D | 7.19 | 12,000 | 86,280 | 0 | |
| Nov 28 2018 | CORI | Corium Internation ... | Gergel Ivan P. | Director | Option Exercise | D | 5.79 | 20,000 | 115,800 | 0 | |
| Dec 05 2017 | CORI | Corium Internation ... | Gergel Ivan P. | Director | Option Exercise | A | 11.59 | 15,000 | 173,850 | 15,000 | |
| Nov 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | A | 14.41 | 50,000 | 720,500 | 50,000 | |
| Nov 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | D | 44.23 | 5,022 | 222,123 | 56,553 | 61.6 K to 56.6 K (-8.16 %) |
| Nov 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Grant | A | 0.00 | 20,000 | 0 | 61,575 | 41.6 K to 61.6 K (+48.11 %) |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | M | 11.04 | 56,704 | 626,012 | 313,752 | |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | M | 11.04 | 43,296 | 477,988 | 370,456 | |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 24.21 | 56,704 | 1,372,804 | 41,575 | 98.3 K to 41.6 K (-57.70 %) |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Buy | M | 11.04 | 56,704 | 626,012 | 98,279 | 41.6 K to 98.3 K (+136.39 %) |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 24.04 | 43,296 | 1,040,836 | 41,575 | 84.9 K to 41.6 K (-51.01 %) |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Buy | M | 11.04 | 43,296 | 477,988 | 84,871 | 41.6 K to 84.9 K (+104.14 %) |
| Aug 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 19.32 | 1,997 | 38,582 | 41,575 | 43.6 K to 41.6 K (-4.58 %) |
| Jul 20 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | M | 11.04 | 54,920 | 606,317 | 413,752 | |
| Jul 20 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 21.10 | 54,920 | 1,158,812 | 43,572 | 98.5 K to 43.6 K (-55.76 %) |
| Jul 20 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Buy | M | 11.04 | 54,920 | 606,317 | 98,492 | 43.6 K to 98.5 K (+126.04 %) |
| Jul 13 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | M | 11.04 | 36,691 | 405,069 | 468,672 | |
| Jul 13 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | M | 11.04 | 8,389 | 92,615 | 505,363 | |
| Jul 13 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 21.09 | 36,691 | 773,813 | 43,572 | 80.3 K to 43.6 K (-45.71 %) |
| Jul 13 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Buy | M | 11.04 | 36,691 | 405,069 | 80,263 | 43.6 K to 80.3 K (+84.21 %) |
| Jul 13 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 21.04 | 8,389 | 176,505 | 43,572 | 52 K to 43.6 K (-16.14 %) |
| Jul 13 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Buy | M | 11.04 | 8,389 | 92,615 | 51,961 | 43.6 K to 52 K (+19.25 %) |
| May 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 19.55 | 1,450 | 28,348 | 43,572 | 45 K to 43.6 K (-3.22 %) |
| Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 13.14 | 1,457 | 19,145 | 45,022 | 46.5 K to 45 K (-3.13 %) |
| Dec 27 2016 | CORI | Corium Internation ... | Gergel Ivan P. | Director | Option Exercise | A | 4.59 | 15,000 | 68,850 | 15,000 | |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | A | 12.24 | 50,000 | 612,000 | 50,000 | |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Grant | A | 0.00 | 20,000 | 0 | 46,479 | 26.5 K to 46.5 K (+75.53 %) |
| Nov 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 13.96 | 848 | 11,838 | 26,479 | 27.3 K to 26.5 K (-3.10 %) |
| Aug 17 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 17.56 | 1,685 | 29,589 | 27,327 | 29 K to 27.3 K (-5.81 %) |
| Jul 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | A | 15.55 | 12,500 | 194,375 | 12,500 | |
| Jul 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
| Jul 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Grant | A | 0.00 | 15,000 | 0 | 16,521 | 1.5 K to 16.5 K (+986.19 %) |
| May 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | D | 0.00 | 1,250 | 0 | 12,500 | |
| May 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 13.58 | 432 | 5,867 | 1,512 | 1.9 K to 1.5 K (-22.22 %) |
| May 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Buy | M | 0.00 | 1,250 | 0 | 1,944 | 694 to 1.9 K (+180.12 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | D | 0.00 | 1,250 | 0 | 13,750 | |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 11.92 | 556 | 6,628 | 694 | 1.3 K to 694 (-44.48 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Buy | M | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
| Feb 05 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | A | 12.21 | 100,000 | 1,221,000 | 100,000 | |
| Dec 22 2015 | CORI | Corium Internation ... | Gergel Ivan P. | Director | Option Exercise | A | 7.19 | 12,000 | 86,280 | 12,000 | |
| Dec 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | A | 15.55 | 15,000 | 233,250 | 15,000 | |
| Dec 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | A | 0.00 | 12,500 | 0 | 12,500 | |
| Jan 08 2008 | FRX | Forest Laboratorie ... | Gergel Ivan | Sr VP - Chief Sci. ... | Option Exercise | A | 37.26 | 30,000 | 1,117,650 | 30,000 | |
| Jan 08 2008 | FRX | Forest Laboratorie ... | Gergel Ivan | Sr VP - Chief Sci. ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Dec 10 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | Sr VP - Chief Sci. ... | Option Exercise | A | 37.26 | 30,000 | 1,117,650 | 30,000 | |
| Dec 10 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | Sr VP - Chief Sci. ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Feb 16 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | SVP Scientific Affa ... | Option Exercise | M | 40.32 | 11,250 | 453,600 | 61,270 | |
| Feb 16 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | SVP Scientific Affa ... | Option Exercise | M | 38.15 | 2,620 | 99,940 | 0 | |
| Feb 16 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | SVP Scientific Affa ... | Option Exercise | M | 38.15 | 18,380 | 701,105 | 0 | |
| Feb 16 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | SVP Scientific Affa ... | Sell | S | 53.50 | 200 | 10,700 | 0 | 200 to 0 (-100.00 %) |
| Feb 16 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | SVP Scientific Affa ... | Sell | S | 53.40 | 17,900 | 955,860 | 200 | 18.1 K to 200 (-98.90 %) |
| Feb 16 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | SVP Scientific Affa ... | Sell | S | 53.43 | 200 | 10,686 | 18,100 | 18.3 K to 18.1 K (-1.09 %) |
| Feb 16 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | SVP Scientific Affa ... | Sell | S | 53.44 | 800 | 42,752 | 18,300 | 19.1 K to 18.3 K (-4.19 %) |
| Feb 16 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | SVP Scientific Affa ... | Sell | S | 53.42 | 6,000 | 320,520 | 19,100 | 25.1 K to 19.1 K (-23.90 %) |
| Feb 16 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | SVP Scientific Affa ... | Sell | S | 53.41 | 2,500 | 133,525 | 25,100 | 27.6 K to 25.1 K (-9.06 %) |
| Feb 16 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | SVP Scientific Affa ... | Sell | S | 53.48 | 1,500 | 80,220 | 27,600 | 29.1 K to 27.6 K (-5.15 %) |
| Feb 16 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | SVP Scientific Affa ... | Sell | S | 53.51 | 100 | 5,351 | 29,100 | 29.2 K to 29.1 K (-0.34 %) |
| Feb 16 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | SVP Scientific Affa ... | Sell | S | 53.49 | 3,050 | 163,145 | 29,200 | 32.3 K to 29.2 K (-9.46 %) |
| Feb 16 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | SVP Scientific Affa ... | Buy | M | 40.32 | 11,250 | 453,600 | 32,250 | 21 K to 32.3 K (+53.57 %) |
| Feb 16 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | SVP Scientific Affa ... | Buy | M | 38.15 | 2,620 | 99,940 | 21,000 | 18.4 K to 21 K (+14.25 %) |
| Feb 16 2007 | FRX | Forest Laboratorie ... | Gergel Ivan | SVP Scientific Affa ... | Buy | M | 38.15 | 18,380 | 701,105 | 18,380 | 0 to 18.4 K |
| Dec 12 2006 | FRX | Forest Laboratorie ... | Gergel Ivan | SVP Scientific Affa ... | Option Exercise | A | 51.54 | 75,000 | 3,865,125 | 75,000 | |
| Jun 21 2005 | FRX | Forest Laboratorie ... | Gergel Ivan | Sr VP - Chief Sci. ... | Option Exercise | M | 21.09 | 11,260 | 237,428 | 0 | |
| Jun 21 2005 | FRX | Forest Laboratorie ... | Gergel Ivan | Sr VP - Chief Sci. ... | Option Exercise | M | 21.09 | 4,740 | 99,948 | 0 | |
| Jun 21 2005 | FRX | Forest Laboratorie ... | Gergel Ivan | Sr VP - Chief Sci. ... | Sell | S | 40.25 | 300 | 12,075 | 0 | 300 to 0 (-100.00 %) |
| Jun 21 2005 | FRX | Forest Laboratorie ... | Gergel Ivan | Sr VP - Chief Sci. ... | Sell | S | 40.24 | 600 | 24,144 | 600 | 1.2 K to 600 (-50.00 %) |
| Jun 21 2005 | FRX | Forest Laboratorie ... | Gergel Ivan | Sr VP - Chief Sci. ... | Sell | S | 40.20 | 500 | 20,100 | 900 | 1.4 K to 900 (-35.71 %) |
| Jun 21 2005 | FRX | Forest Laboratorie ... | Gergel Ivan | Sr VP - Chief Sci. ... | Sell | S | 40.21 | 1,000 | 40,210 | 1,400 | 2.4 K to 1.4 K (-41.67 %) |
| Jun 21 2005 | FRX | Forest Laboratorie ... | Gergel Ivan | Sr VP - Chief Sci. ... | Sell | S | 40.22 | 5,500 | 221,210 | 2,400 | 7.9 K to 2.4 K (-69.62 %) |
| Jun 21 2005 | FRX | Forest Laboratorie ... | Gergel Ivan | Sr VP - Chief Sci. ... | Sell | S | 40.23 | 8,100 | 325,863 | 7,900 | 16 K to 7.9 K (-50.62 %) |
| Jun 21 2005 | FRX | Forest Laboratorie ... | Gergel Ivan | Sr VP - Chief Sci. ... | Buy | M | 21.09 | 11,260 | 237,428 | 16,000 | 4.7 K to 16 K (+237.55 %) |
| Jun 21 2005 | FRX | Forest Laboratorie ... | Gergel Ivan | Sr VP - Chief Sci. ... | Buy | M | 21.09 | 4,740 | 99,948 | 4,740 | 0 to 4.7 K |
Page: 1